Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06722261 · ClinicalTrials.gov registry record · NA

Single Case Research Design: Deaf Children's Language Outcomes

A NA study of Language Development, sponsored by The University of Tennessee, Knoxville.

Active
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT06722261: Active NA study of Language Development, sponsored by The University of Tennessee, Knoxville.

NCT06722261 is a NA study of Language Development that is active but no longer recruiting, run by The University of Tennessee, Knoxville. The registered enrollment target is 8 participants, below the 107-participant average among 13 other Language Development trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06722261, a NA study of Language Development, is active but no longer recruiting, sponsored by The University of Tennessee, Knoxville.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

Eight deaf children in kindergarten to 3rd grade classes will be randomly selected for single case research. Their language skills will be monitored and assessed daily. Using a noncurrent multiple baseline design (Single Case Research Design or SCRD), Strategic and Interactive Signing Instruction (SISI) will be administered to two children in each of four classes.

Primary Outcome

Deaf children's development of target sign language skills will be documented.

Conditions Studied

Interventions

  • BEHAVIORAL Strategic and Interactive Signing Instruction

Study Locations (1)

Tennessee

  • University of Tennessee, Knoxville - Knoxville

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2025-08-01
Est. Completion 2026-11-30
Phase NA

What the registry record for NCT06722261 still lists

NCT06722261 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 107-participant average among 13 other Language Development trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Language Development appearing as the primary indexed condition, and to 1 intervention - of which Strategic and Interactive Signing Instruction is the first listed.

NCT06722261 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT06722261 about?

NCT06722261 is a clinical study titled "Single Case Research Design: Deaf Children's Language Outcomes". Eight deaf children in kindergarten to 3rd grade classes will be randomly selected for single case research. Their language skills will be monitored and assessed daily. Using a noncurrent multiple baseline design (Single Case Research Design or SCRD), Strategic and Interactive Signing Instruction (S...

What is the current status of trial NCT06722261?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2025-08-01. Estimated completion is 2026-11-30.

What conditions does trial NCT06722261 study?

This clinical trial studies the following conditions: Language Development.

What interventions are being tested in trial NCT06722261?

The interventions under investigation include: Strategic and Interactive Signing Instruction (BEHAVIORAL).

Who is sponsoring clinical trial NCT06722261?

This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06722261 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Language Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06722261's enrollment target sits among peer trials

8 14th of 13 the lowest of 13 other Language Development trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Language Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06722261, the US trial registry maintained by the National Library of Medicine. NCT06722261 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.